Comments
Dr Reddy's Laboratories has informed the BSE that it has settled claims with the Ottawa, Canada-based Nordion Inc (formerly MDS Inc.).
In the case pending in the New Jersey District Court of the US, Nordion settled the case against it by paying $22.5 million (Rs 122.27 crore) to DRL. The settlement was concluded on March 20.
The case was brought by DRL in April 2009 seeking damages caused by a claimed breach by the former MDS of its laboratory services agreement with it (DRL).
The Canadian company, as a contract research firm, provided lab services to Dr Reddy’s, including bio-equivalency studies to support its regulatory applications for approval of generic drugs.
PTI adds: “The case arose after the USFDA cited MDS with violations of good laboratory practices which caused the USFDA not to accept, without further substantiation, MDS’s laboratory reports performed during the period 2000-2004,” Dr Reddy's said in a statement.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.